Literature DB >> 5532919

Bacteriologic and pharmacodynamic aspects of nalidixic acid.

L H Harrison, C E Cox.   

Abstract

Entities:  

Mesh：

Year:  1970        PMID： 5532919

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  6 in total

1.  Comparative in vitro studies of nalidixic acid, oxolinic acid, and a new analog with thieno (2,3-b) pyridine structure.

Authors:  P M Gilis; A Haemers; S R Pattyn
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

2.  Factors governing the emergence of resistance to nalidixic acid in treatment of urinary tract infection.

Authors:  D Greenwood; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

3.  The place of quinolones in antibacterial therapy in hospitals.

Authors:  R P Mouton
Journal:  Pharm Weekbl Sci       Date:  1986-02-21

4.  Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid.

Authors:  R M Lumish; C W Norden
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

5.  Comparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women.

Authors:  A Iravani; G A Richard; H Baer; R Fennell
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

6.  Pharmacology of cinoxacin in humans.

Authors:  H R Black; K S Israel; R L Wolen; G L Brier; B D Obermeyer; E A Ziege; J D Wolny
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.